Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2025)

Dexcom (DXCM) has disclosed Long-Term Deferred Tax for 6 consecutive years, with $375.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 22.8% to $375.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $375.6 million, a 22.8% decrease, with the full-year FY2024 number at $481.2 million, up 14.74% from a year prior.
  • Long-Term Deferred Tax was $375.6 million for Q3 2025 at Dexcom, down from $496.3 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $501.3 million in Q3 2023 to a low of $216.3 million in Q3 2021.
  • A 5-year average of $377.6 million and a median of $375.6 million in 2025 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 58.25% in 2022, then dropped 22.8% in 2025.
  • Dexcom's Long-Term Deferred Tax stood at $290.5 million in 2021, then grew by 17.45% to $341.2 million in 2022, then increased by 22.92% to $419.4 million in 2023, then grew by 14.74% to $481.2 million in 2024, then dropped by 21.95% to $375.6 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Long-Term Deferred Tax are $375.6 million (Q3 2025), $496.3 million (Q2 2025), and $487.3 million (Q1 2025).